Literature DB >> 2983208

Etoposide (VP-16-213). Current status of an active anticancer drug.

P J O'Dwyer, B Leyland-Jones, M T Alonso, S Marsoni, R E Wittes.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 2983208     DOI： 10.1056/NEJM198503143121106

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  62 in total

1.  Intra-arterial cisplatin plus oral etoposide for the treatment of recurrent malignant glioma: a phase II study.

Authors:  L S Ashby; W R Shapiro
Journal:  J Neurooncol       Date:  2001-01       Impact factor: 4.130

2.  Effect of isopropyl myristic acid ester on the physical characteristics and in vitro release of etoposide from PLGA microspheres.

Authors:  M J Schaefer; J Singh
Journal:  AAPS PharmSciTech       Date:  2000-11-13       Impact factor: 3.246

Review 3.  Effect of haemodialysis on the pharmacokinetics of antineoplastic drugs.

Authors:  Masatoshi Tomita; Yoichi Aoki; Kenichi Tanaka
Journal:  Clin Pharmacokinet       Date:  2004       Impact factor: 6.447

Review 4.  Etoposide phosphate, the water soluble prodrug of etoposide.

Authors:  A H Witterland; C H Koks; J H Beijnen
Journal:  Pharm World Sci       Date:  1996-10

5.  Modification of the 8 drugs in 1 day regimen: feasibility of substitution of other agents.

Authors:  K W Chan; C J Fryer; P Steinbok
Journal:  J Neurooncol       Date:  1990-10       Impact factor: 4.130

Review 6.  Do anticancer agents reach the tumor target in the human brain?

Authors:  M G Donelli; M Zucchetti; M D'Incalci
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

7.  High dose folinic acid/etoposide/5-fluorouracil in advanced gastric cancer--a phase II study in elderly patients or patients with cardiac risk.

Authors:  H Wilke; P Preusser; U Fink; W Achterrath; L Lenaz; M Stahl; C Schober; H Link; H J Meyer; B Lucke
Journal:  Invest New Drugs       Date:  1990-02       Impact factor: 3.850

8.  Carboplatin in association with etoposide and either adriamycin or epirubicin for untreated small cell lung cancer: a dose escalation study of carboplatin. UCL Clinical Oncology Group.

Authors:  Y Humblet; P Weynants; A Bosly; F Majois; P Duprez; C Francis; M Beauduin; J Machiels; C Gailly; L Delaunois
Journal:  Med Oncol Tumor Pharmacother       Date:  1989

9.  Cytotoxic properties of a new synthetic demethylpodophyllotoxin derivative, BN 58705, against human tumor cell lines.

Authors:  H Morimoto; P Principe; J P Robin; C Broquet; J M Mencia-Huerta; P Braquet; B Bonavida
Journal:  Cancer Chemother Pharmacol       Date:  1993       Impact factor: 3.333

10.  Pharmacokinetics of etoposide in rats with uranyl nitrate (UN)-induced acute renal failure (ARF): optimization of the duration of UN dosing.

Authors:  P Venkatesh; T Harisudhan; Hira Choudhury; Ramesh Mullangi; Nuggehally R Srinivas
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2007 Oct-Dec       Impact factor: 2.441
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.